Zana Medical - Medical Decision support system

Industry

Clinical decision support system to help cannabis patients manage treatment.

We've created a personalized treatment solution that integrates over 80 biomarkers and behavioral data points, alongside the specific patient condition, to formulate a recommended treatment regimen to improve their therapeutic outcomes.
We've developed patient-centered, remote patient monitoring system to continuously gathered patient health data.
Utilizing machine learning technologies and collaborating with top academic institutions both domestically and internationally, we've developed sophisticated data models to advance our understanding of how specific cannabinoids impact various conditions.
We created an AI bot that responds to patients' treatment requests and offers them guidance. This system resulted in a 38% increase in patient engagement and a 23% improvement in patient symptom management.

‍

Zana Medical is the first digital health company to use a clinical decision support platform partnered with an in-person advisory team to treat chronic conditions using cannabis. The platform combines a digital guidance and mobile monitoring system to answer critical questions, including intake method, dosage, medicine type, and place of purchase. With exclusive access to over 150,000 patients, ZMG is committed to providing reliable information and improving healthcare outcomes for all.

‍

Problem

patients seeking medical cannabis treatments: the lack of reliable information and guidance. Consumers often struggle to make informed decisions due to the overwhelming amount of inaccurate and conflicting information within the industry.

Solution

To address the issue with helped Zana, design and develop a personalized treatment approach that integrates over 80 biomarkers and behavioral data points, allowing us to tailor treatment regimens to individual patient conditions. This ensures that patients receive recommendations that are specifically suited to their needs, ultimately improving their therapeutic outcomes.

In addition to personalized treatment plans, we implemented a remote patient monitoring system utilizing mobile technologies. This system continuously gathers patient health data, providing real-time insights into their condition and enabling proactive care management.

Our commitment to advancing medical cannabis treatments led us to collaborate with top academic institutions, both domestically and internationally. Through these partnerships, we've developed sophisticated data models to deepen our understanding of how specific cannabinoids impact various medical conditions. This evidence-based approach guides our treatment recommendations, ensuring that patients receive the most effective care possible.

Recognizing the need for accessible guidance, we created an AI bot that responds to patients' treatment requests and offers personalized guidance. This innovative system has resulted in a 38% increase in patient engagement and a 23% improvement in patient symptom management, demonstrating the tangible impact of our solution.

‍